Study of Recombinant Factor IX Product, IB1001, in Previously Treated Subjects With Hemophilia B
Clinical trial NCT02048111 · WITHDRAWN
Trial details
- NCT number
- NCT02048111
- Sponsor
- Cangene Corporation
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2015-10-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.